期刊文献+
共找到145篇文章
< 1 2 8 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
INTRODUCTIONHepatolenticulardegeneration(HLD)isanautosomalrecesivedisorderthatcauseschangesinthebasalganglia... INTRODUCTIONHepatolenticulardegeneration(HLD)isanautosomalrecesivedisorderthatcauseschangesinthebasalgangliaandliverthatrespe... 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
7
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
分析低分子肝素治疗急性缺血性脑血管病的效果
8
作者 王海娟 于明娜 李英真 《系统医学》 2024年第4期114-116,128,共4页
目的 分析治疗急性缺血性脑血管病使用低分子肝素的疗效。方法 选取2020年3月—2023年3月曹县人民医院神经内科收治的80例急性缺血性脑血管病患者作为研究对象,按入院顺序进行编号,其中奇数号患者为对照组(n=40),使用复方丹参注射液治疗... 目的 分析治疗急性缺血性脑血管病使用低分子肝素的疗效。方法 选取2020年3月—2023年3月曹县人民医院神经内科收治的80例急性缺血性脑血管病患者作为研究对象,按入院顺序进行编号,其中奇数号患者为对照组(n=40),使用复方丹参注射液治疗;偶数号为研究组(n=40),使用低分子肝素治疗。观察两组患者的脑神经功能、生活水平、不良反应和治疗效果。结果 治疗前,两组患者脑神经功能和生活水平评分比较,差异无统计学意义(P均>0.05);治疗后,研究组脑神经功能和生活水平评分低于对照组,差异有统计学意义(P均<0.05)。研究组患者的不良反应总发生率为2.50%,低于对照组的15.00%,差异有统计学意义(χ^(2)=3.914,P<0.05)。研究组的治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论 使用低分子肝素治疗的患者,其神经功能恢复明显,生活水平高,不良反应发生率低,治疗效果显著。 展开更多
关键词 急性缺血性脑血管病 低分子肝素 脑神经功能 不良反应 治疗效果
下载PDF
Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin 被引量:24
9
作者 Cui HF Jiang XL 《World Journal of Gastroenterology》 SCIE CAS CSCD 1999年第5期448-450,共3页
关键词 COLITIS ulcerative/drug therapy heparin/therapertic use corticosteroidresistant
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
10
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
11
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
低分子肝素对结直肠癌患者术后静脉血栓栓塞的治疗效果观察 被引量:2
12
作者 史敬东 王鹏辉 +1 位作者 齐中 汪岩 《血管与腔内血管外科杂志》 2023年第5期540-543,共4页
目的观察低分子肝素对结直肠癌患者术后静脉血栓栓塞(VTE)的治疗效果。方法收集2016年1月至2023年1月于首都医科大学附属北京天坛医院收治的72例结直肠癌术后发生VTE的患者的临床资料,根据治疗方法的不同将患者分为常规组(接受常规治疗... 目的观察低分子肝素对结直肠癌患者术后静脉血栓栓塞(VTE)的治疗效果。方法收集2016年1月至2023年1月于首都医科大学附属北京天坛医院收治的72例结直肠癌术后发生VTE的患者的临床资料,根据治疗方法的不同将患者分为常规组(接受常规治疗)和观察组(在常规治疗的基础上接受低分子肝素治疗),每组36例。比较两组患者的手术相关指标,包括手术时间、术中出血量、下床活动时间、总住院时间。比较两组患者治疗前(确诊VTE时)、治疗后(治疗14 d后)的凝血功能指标[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)水平、D-二聚体(D-D)水平]和下肢静脉系统的平均血流速度。结果观察组患者的下床活动时间、总住院时间均明显短于常规组患者,差异均有统计学意义(P﹤0.01)。治疗后,观察组患者的PT、APTT均长于常规组患者,FIB、D-D水平均低于常规组患者,差异均有统计学意义(P﹤0.05)。治疗后,观察组患者股总静脉、股深静脉、股浅静脉、胫后静脉、胫前静脉的平均血流速度均快于常规组患者,差异均有统计学意义(P﹤0.05)。结论低分子肝素能够提高对结直肠癌患者术后VTE的治疗效果,提高患者下肢静脉血流速度,改善患者的凝血功能。 展开更多
关键词 结直肠癌 低分子肝素 静脉血栓栓塞 治疗效果 凝血功能
下载PDF
低分子肝素联合泼尼松在小儿肾病综合征治疗中的应用价值分析
13
作者 葛婷婷 张林 《世界复合医学》 2023年第5期191-194,共4页
目的 探讨小儿肾病综合征患者采用低分子肝素+泼尼松药物治疗的临床效果。方法 选取2020年1月—2022年12月无锡市儿童医院收治的64例小儿肾病综合征患者为研究对象;以投掷硬币法作为分组依据,其中施以泼尼松药物治疗的设为参照组(n=32)... 目的 探讨小儿肾病综合征患者采用低分子肝素+泼尼松药物治疗的临床效果。方法 选取2020年1月—2022年12月无锡市儿童医院收治的64例小儿肾病综合征患者为研究对象;以投掷硬币法作为分组依据,其中施以泼尼松药物治疗的设为参照组(n=32),施以低分子肝素+泼尼松药物治疗的设为研究组(n=32)。对比两组治疗总有效率、肾功能指标、凝血指标、血清总胆固醇、白蛋白、24 h尿蛋白定量。结果 研究组治疗总有效率96.88%同参照组比较,差异有统计学意义(χ^(2)=4.655,P<0.05)。治疗后,研究组内生肌酐清除率水平(115.71±4.69)mL/min、血肌酐水平(56.16±10.12)μmol/L、尿素氮水平(6.02±0.55)mmol/L同参照组比较,差异有统计学意义(P<0.05)。治疗后,两组部分活化凝血酶原时间、血浆凝血酶原时间比较,差异无统计学意义(P>0.05)。治疗后,研究组总胆固醇、白蛋白水平,24 h尿蛋白定量同参照组比较,差异有统计学意义(P<0.05)。结论 临床对小儿肾病综合征患者给予低分子肝素+泼尼松药物治疗,可显著改善患儿的肾功能等,获得较好的预后效果。 展开更多
关键词 低分子肝素 泼尼松 小儿肾病综合征 治疗效果
下载PDF
早期神经介入栓塞治疗老年破裂颅内动脉瘤患者的临床优势 被引量:7
14
作者 孙建萍 吕斌 +4 位作者 张荣举 刘新峰 曹向宇 王君 杜志华 《中华老年心脑血管病杂志》 CAS 北大核心 2023年第1期53-56,共4页
目的探析早期神经介入栓塞在老年破裂颅内动脉瘤患者治疗中的应用效果。方法连续收集2014年1月至2020年10月在解放军总医院第一医学中心神经内科住院的老年破裂颅内动脉瘤患者68例,采用随机数字表法分为对照组(32例)和观察组(36例)。观... 目的探析早期神经介入栓塞在老年破裂颅内动脉瘤患者治疗中的应用效果。方法连续收集2014年1月至2020年10月在解放军总医院第一医学中心神经内科住院的老年破裂颅内动脉瘤患者68例,采用随机数字表法分为对照组(32例)和观察组(36例)。观察组于早期实施神经介入栓塞治疗(动脉瘤破裂后24 h内),对照组于非早期神经介入治疗(动脉瘤破裂24 h后),比较2组卧床时间、住院时间、美国国立卫生研究院卒中量表(NIHSS)评分、并发症发生率及栓塞程度。结果观察组卧床时间、住院时间显著短于对照组[(4.95±1.15)d vs(6.42±0.89)d,(10.21±2.34)d vs(14.57±2.31)d,P=0.000];观察组完全栓塞比例显著高于对照组(88.89%vs 68.75%,P=0.040);2组入院时及术后2周NIHSS评分、肺部感染、再破裂出血、下肢静脉血栓、脑水肿发生率、大部分栓塞、部分栓塞比例比较,差异无统计学意义(P>0.05)。结论早期神经介入栓塞术在老年破裂颅内动脉瘤患者治疗中应用效果显著,其有助于患者神经功能、生活自理能力改善,且能够降低并发症发生率。 展开更多
关键词 动脉瘤 破裂 栓塞 治疗性 血管内操作 肝素
下载PDF
低分子肝素钙与氯吡格雷联合治疗进展性缺血性脑卒中的临床效果分析 被引量:3
15
作者 张雅丽 《中国实用医药》 2023年第6期123-125,共3页
目的 探讨进展性缺血性脑卒中患者采用低分子肝素钙+氯吡格雷治疗的临床效果。方法 88例进展性缺血性脑卒中患者,采用随机数字表法分为参照组与研究组,各44例。参照组在常规治疗基础上采用低分子肝素钙治疗,研究组在参照组基础上采用氯... 目的 探讨进展性缺血性脑卒中患者采用低分子肝素钙+氯吡格雷治疗的临床效果。方法 88例进展性缺血性脑卒中患者,采用随机数字表法分为参照组与研究组,各44例。参照组在常规治疗基础上采用低分子肝素钙治疗,研究组在参照组基础上采用氯吡格雷治疗。比较两组患者治疗效果、治疗前后神经功能障碍量表(NDS)评分、用药不良反应(恶心、头痛、腹泻、牙龈出血、便秘)发生情况。结果 研究组患者治疗总有效率95.45%高于参照组的72.73%,差异具有统计学意义(P<0.05)。治疗后,研究组患者NDS评分(10.03±2.11)分低于参照组的(16.25±3.99)分,差异具有统计学意义(P<0.05)。研究组患者不良反应发生率9.09%与参照组的6.82%比较,差异无统计学意义(P>0.05)。结论 低分子肝素钙+氯吡格雷治疗进展性缺血性脑卒中,可以提高用药疗效,改善患者神经功能、临床症状,并且可保证用药安全性。 展开更多
关键词 低分子肝素钙 氯吡格雷 进展性缺血性脑卒中 治疗效果
下载PDF
颅脑创伤长期卧床患者下肢静脉血栓形成预防措施的对照性研究
16
作者 罗朝军 王首勇 +5 位作者 杨安强 林绍云 王绍怀 刘强 王谦 彭德鹏 《按摩与康复医学》 2023年第10期22-25,29,共5页
目的:对比颅脑创伤长期卧床患者下肢静脉血栓形成不同预防措施的效果。方法:将颅脑创伤长期卧床患者随机分为三组收集数据,共收集病例333例,物理预防组(n=121),药物预防组(n=108),中医手法组(n=104),物理预防组使用空气波压力循环治疗... 目的:对比颅脑创伤长期卧床患者下肢静脉血栓形成不同预防措施的效果。方法:将颅脑创伤长期卧床患者随机分为三组收集数据,共收集病例333例,物理预防组(n=121),药物预防组(n=108),中医手法组(n=104),物理预防组使用空气波压力循环治疗仪、药物预防组使用低分子肝素钠、中医手法组采用穴位按摩及下肢主动被动运动进行预防,干预7天后统计分析下肢静脉血流动力学指标、凝血指标及临床指标(下肢肿胀、DVT、肺栓塞发生率及预防费用)。结果:干预后,三组平均血流量、平均血流速度及峰流速均高于干预前(P<0.05),物理预防组与中医手法组平均血流量、平均血流速度及峰流速高于药物预防组(P<0.05),物理预防组与中医手法组间差异无统计学意义(P>0.05)。干预后,三组D-D、PT及FIB均低于干预前(P<0.05);三组干预后D-D、PT及FIB比较,差异无统计学意义(P>0.05)。干预后,三组下肢肿胀、DVT、肺栓塞发生率及预防费用差异无统计学意义(P>0.05)。结论:物理预防、药物预防及中医手法预防对颅脑创伤长期卧床患者下肢静脉血栓形成均是有效的,中医手法预防无明显禁忌症,适用于绝大部分患者,其不良反应率低、性价比高,对设备、药物依赖性小,操作简单,值得在偏远贫穷地区基层医院推荐开展。 展开更多
关键词 颅脑创伤 下肢静脉血栓 空气波压力循环治疗仪 低分子肝素钠 中医手法 预防
下载PDF
The role of drug utilization evaluation in medical sciences
17
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
低分子肝素钠治疗急性缺血性结肠炎的临床有效性分析
18
作者 庄莉 阮明文 高智杰 《中外医疗》 2023年第28期81-84,共4页
目的探索急性缺血性结肠炎患者临床治疗时运用低分子肝素钠的价值。方法方便选择2020年6月—2022年6月南靖县医院收治的76例急性缺血性结肠炎患者为研究对象。以随机数表法分为两组,每组38例,对照组治疗药物为参酮ⅡA磺酸钠注射液;观察... 目的探索急性缺血性结肠炎患者临床治疗时运用低分子肝素钠的价值。方法方便选择2020年6月—2022年6月南靖县医院收治的76例急性缺血性结肠炎患者为研究对象。以随机数表法分为两组,每组38例,对照组治疗药物为参酮ⅡA磺酸钠注射液;观察组治疗药物在对照组的基础上增加低分子肝素钠,两组患者均连续接受14 d的治疗。对比两组患者临床治疗效果、凝血指标与炎症指标、缺血性结肠炎症状评分、不良反应发生率。结果治疗后,观察组治疗总有效率为94.74%高于对照组的78.95%,差异有统计学意义(χ^(2)=4.145,P<0.05);治疗前,两组患者凝血指标与炎症指标比较,差异无统计学意义(P>0.05),治疗后,观察组凝血及炎症指标均优于对照组,差异有统计学意义(P<0.05);治疗前,两组患者症状评分比较,差异无统计学意义(P>0.05),治疗后,观察组症状评分显著低于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论急性缺血性结肠炎予以低分子肝素钠治疗能够进一步提升临床疗效,改善机体凝血指标及炎症水平,促进症状缓解,用药后不良反应少,安全性有所保障。 展开更多
关键词 急性缺血性结肠炎 低分子肝素钠 治疗效果 凝血指标 炎症因子
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
19
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
低分子肝素钠联合地屈孕酮治疗先兆流产的临床观察 被引量:84
20
作者 李慧 吴小妹 周玉华 《中国药房》 CAS 北大核心 2017年第18期2499-2502,共4页
目的:观察低分子肝素钠联合地屈孕酮治疗先兆流产的疗效和安全性。方法:回顾性分析72例先兆流产妊娠期妇女资料,按用药的不同分为对照组(36例)和观察组(36例)。对照组妊娠期妇女口服地屈孕酮片起始剂量40 mg,1日后每12 h 1次,每次10 mg... 目的:观察低分子肝素钠联合地屈孕酮治疗先兆流产的疗效和安全性。方法:回顾性分析72例先兆流产妊娠期妇女资料,按用药的不同分为对照组(36例)和观察组(36例)。对照组妊娠期妇女口服地屈孕酮片起始剂量40 mg,1日后每12 h 1次,每次10 mg。观察组妊娠期妇女在对照组治疗的基础给予低分子肝素钠注射液5 000 U,腹壁皮下注射,每日1次。两组均用药1周。观察两组妊娠期妇女的临床疗效,腰酸、阴道流血、腹痛时间及总治疗时间,新生儿出生体质量、妊娠期妇女分娩时妊娠天数,治疗前后超敏C反应蛋白(hs-CRP)、纤维蛋白原、D-二聚体、血小板水平及不良反应发生情况。结果:观察组妊娠期妇女总有效率显著高于对照组(91.7%vs.80.6%),腰酸、阴道流血、腹痛时间及总治疗时间均显著短于对照组,新生儿出生体质量、妊娠期妇女分娩时妊娠天数均显著多于对照组,差异均有统计学意义(P<0.05)。治疗前,两组妊娠期妇女hs-CRP、纤维蛋白原、D-二聚体、血小板水平比较,差异均无统计学意义(P>0.05);治疗后,两组妊娠期妇女hs-CRP、纤维蛋白原、D-二聚体、血小板水平均显著低于同组治疗前,且观察组显著低于对照组,差异均有统计学意义(P<0.05)。两组妊娠期妇女不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在常规治疗的基础上,低分子肝素钠联合地屈孕酮治疗先兆流产的疗效和安全性均较好。 展开更多
关键词 低分子肝素钠 地屈孕酮 先兆流产 疗效 安全性
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部